GATA3 and HDAC1 |
GATA binding protein 3 |
histone deacetylase 1 |
- Ub-specific processing proteases
- Interleukin-4 and Interleukin-13 signaling
- RUNX1 regulates transcription of genes involved in differentiation of HSCs
- Estrogen-dependent gene expression
- Factors involved in megakaryocyte development and platelet production
|
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- G0 and Early G1
- p75NTR negatively regulates cell cycle via SC1
- Formation of the beta-catenin:TCF transactivating complex
- NOTCH1 Intracellular Domain Regulates Transcription
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- HDACs deacetylate histones
- Notch-HLH transcription pathway
- Deactivation of the beta-catenin transactivating complex
- ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
- NoRC negatively regulates rRNA expression
- SUMOylation of chromatin organization proteins
- Repression of WNT target genes
- Repression of WNT target genes
- Regulation of TP53 Activity through Acetylation
- G1/S-Specific Transcription
- RNA Polymerase I Transcription Initiation
- RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
- Estrogen-dependent gene expression
- Loss of MECP2 binding ability to 5mC-DNA
- Regulation of MECP2 expression and activity
- MECP2 regulates neuronal receptors and channels
- MECP2 regulates transcription of neuronal ligands
- FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
- Factors involved in megakaryocyte development and platelet production
|
|
- Arsenic trioxide
- Zinc
- Vorinostat
- Belinostat
- Pracinostat
- Romidepsin
- Panobinostat
- Fingolimod
- Mocetinostat
- Abexinostat
|
|
|
GATA3 and FBXW7 |
GATA binding protein 3 |
F-box and WD repeat domain containing 7 |
- Ub-specific processing proteases
- Interleukin-4 and Interleukin-13 signaling
- RUNX1 regulates transcription of genes involved in differentiation of HSCs
- Estrogen-dependent gene expression
- Factors involved in megakaryocyte development and platelet production
|
- Association of TriC/CCT with target proteins during biosynthesis
- Neddylation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
|
B4GALT1 and CDK11A |
beta-1,4-galactosyltransferase 1 |
cyclin dependent kinase 11A |
- Pre-NOTCH Processing in Golgi
- Keratan sulfate biosynthesis
- Interaction With Cumulus Cells And The Zona Pellucida
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Lactose synthesis
- Neutrophil degranulation
- N-Glycan antennae elongation
|
- Recruitment of mitotic centrosome proteins and complexes
|
- N-Acetylglucosamine
- 6-Aminohexyl-Uridine-C1,5'-Diphosphate
- Di(N-Acetyl-D-Glucosamine)
- Galactose-uridine-5'-diphosphate
- Uridine monophosphate
- 2-(N-Morpholino)-Ethanesulfonic Acid
|
|
- Congenital disorders of glycosylation (CDG) type II
|
|
B4GALT1 and TUBA1A |
beta-1,4-galactosyltransferase 1 |
tubulin alpha 1a |
- Pre-NOTCH Processing in Golgi
- Keratan sulfate biosynthesis
- Interaction With Cumulus Cells And The Zona Pellucida
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Lactose synthesis
- Neutrophil degranulation
- N-Glycan antennae elongation
|
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
- Gap junction assembly
- MHC class II antigen presentation
- Separation of Sister Chromatids
- Resolution of Sister Chromatid Cohesion
- Regulation of PLK1 Activity at G2/M Transition
- HSP90 chaperone cycle for steroid hormone receptors (SHR)
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Prefoldin mediated transfer of substrate to CCT/TriC
- Formation of tubulin folding intermediates by CCT/TriC
- Post-chaperonin tubulin folding pathway
- Recycling pathway of L1
- Recycling pathway of L1
- Hedgehog 'off' state
- Cilium Assembly
- Anchoring of the basal body to the plasma membrane
- Intraflagellar transport
- RHO GTPases activate IQGAPs
- RHO GTPases Activate Formins
- COPI-mediated anterograde transport
- COPI-dependent Golgi-to-ER retrograde traffic
- COPI-independent Golgi-to-ER retrograde traffic
- Mitotic Prometaphase
- The role of GTSE1 in G2/M progression after G2 checkpoint
- AURKA Activation by TPX2
- Carboxyterminal post-translational modifications of tubulin
- Carboxyterminal post-translational modifications of tubulin
- HCMV Early Events
- Assembly and cell surface presentation of NMDA receptors
- Activation of AMPK downstream of NMDARs
- Aggrephagy
- Aggrephagy
- EML4 and NUDC in mitotic spindle formation
- Sealing of the nuclear envelope (NE) by ESCRT-III
- Kinesins
|
- N-Acetylglucosamine
- 6-Aminohexyl-Uridine-C1,5'-Diphosphate
- Di(N-Acetyl-D-Glucosamine)
- Galactose-uridine-5'-diphosphate
- Uridine monophosphate
- 2-(N-Morpholino)-Ethanesulfonic Acid
|
- Albendazole
- Vinblastine
- Mebendazole
- Epothilone D
- Patupilone
- CYT997
- 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE
- Artenimol
- Phenethyl Isothiocyanate
|
- Congenital disorders of glycosylation (CDG) type II
|
- Lissencephaly (LIS); Miller-Dieker syndrome (MDLS)
|
B4GALT1 and TUBB |
beta-1,4-galactosyltransferase 1 |
tubulin beta class I |
- Pre-NOTCH Processing in Golgi
- Keratan sulfate biosynthesis
- Interaction With Cumulus Cells And The Zona Pellucida
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Lactose synthesis
- Neutrophil degranulation
- N-Glycan antennae elongation
|
- Regulation of PLK1 Activity at G2/M Transition
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Anchoring of the basal body to the plasma membrane
- Neutrophil degranulation
- AURKA Activation by TPX2
|
- N-Acetylglucosamine
- 6-Aminohexyl-Uridine-C1,5'-Diphosphate
- Di(N-Acetyl-D-Glucosamine)
- Galactose-uridine-5'-diphosphate
- Uridine monophosphate
- 2-(N-Morpholino)-Ethanesulfonic Acid
|
- Vinorelbine
- Vincristine
- Vinblastine
- Podofilox
- Colchicine
- Epothilone D
- Patupilone
- CYT997
- CA4P
- ZEN-012
- Copper
- Depatuxizumab mafodotin
- Milataxel
|
- Congenital disorders of glycosylation (CDG) type II
|
|
B4GALT1 and LALBA |
beta-1,4-galactosyltransferase 1 |
lactalbumin alpha |
- Pre-NOTCH Processing in Golgi
- Keratan sulfate biosynthesis
- Interaction With Cumulus Cells And The Zona Pellucida
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Lactose synthesis
- Neutrophil degranulation
- N-Glycan antennae elongation
|
|
- N-Acetylglucosamine
- 6-Aminohexyl-Uridine-C1,5'-Diphosphate
- Di(N-Acetyl-D-Glucosamine)
- Galactose-uridine-5'-diphosphate
- Uridine monophosphate
- 2-(N-Morpholino)-Ethanesulfonic Acid
|
|
- Congenital disorders of glycosylation (CDG) type II
|
|
B4GALT1 and TUBA4A |
beta-1,4-galactosyltransferase 1 |
tubulin alpha 4a |
- Pre-NOTCH Processing in Golgi
- Keratan sulfate biosynthesis
- Interaction With Cumulus Cells And The Zona Pellucida
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Lactose synthesis
- Neutrophil degranulation
- N-Glycan antennae elongation
|
- Platelet degranulation
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
- Gap junction assembly
- MHC class II antigen presentation
- Separation of Sister Chromatids
- Resolution of Sister Chromatid Cohesion
- Regulation of PLK1 Activity at G2/M Transition
- HSP90 chaperone cycle for steroid hormone receptors (SHR)
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Prefoldin mediated transfer of substrate to CCT/TriC
- Formation of tubulin folding intermediates by CCT/TriC
- Post-chaperonin tubulin folding pathway
- Recycling pathway of L1
- Recycling pathway of L1
- Hedgehog 'off' state
- Cilium Assembly
- Anchoring of the basal body to the plasma membrane
- Intraflagellar transport
- RHO GTPases activate IQGAPs
- RHO GTPases Activate Formins
- COPI-mediated anterograde transport
- COPI-dependent Golgi-to-ER retrograde traffic
- COPI-independent Golgi-to-ER retrograde traffic
- Mitotic Prometaphase
- The role of GTSE1 in G2/M progression after G2 checkpoint
- AURKA Activation by TPX2
- Carboxyterminal post-translational modifications of tubulin
- Carboxyterminal post-translational modifications of tubulin
- HCMV Early Events
- Assembly and cell surface presentation of NMDA receptors
- Activation of AMPK downstream of NMDARs
- Aggrephagy
- Aggrephagy
- EML4 and NUDC in mitotic spindle formation
- Sealing of the nuclear envelope (NE) by ESCRT-III
- Kinesins
|
- N-Acetylglucosamine
- 6-Aminohexyl-Uridine-C1,5'-Diphosphate
- Di(N-Acetyl-D-Glucosamine)
- Galactose-uridine-5'-diphosphate
- Uridine monophosphate
- 2-(N-Morpholino)-Ethanesulfonic Acid
|
- Vincristine
- Podofilox
- Epothilone D
- Patupilone
- CYT997
- S-8184
- Cabazitaxel
- Phenethyl Isothiocyanate
|
- Congenital disorders of glycosylation (CDG) type II
|
|
B4GALT1 and TFRC |
beta-1,4-galactosyltransferase 1 |
transferrin receptor |
- Pre-NOTCH Processing in Golgi
- Keratan sulfate biosynthesis
- Interaction With Cumulus Cells And The Zona Pellucida
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
- Lactose synthesis
- Neutrophil degranulation
- N-Glycan antennae elongation
|
- Golgi Associated Vesicle Biogenesis
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- Transferrin endocytosis and recycling
|
- N-Acetylglucosamine
- 6-Aminohexyl-Uridine-C1,5'-Diphosphate
- Di(N-Acetyl-D-Glucosamine)
- Galactose-uridine-5'-diphosphate
- Uridine monophosphate
- 2-(N-Morpholino)-Ethanesulfonic Acid
|
|
- Congenital disorders of glycosylation (CDG) type II
|
|
GLP1R and TMCO3 |
glucagon like peptide 1 receptor |
transmembrane and coiled-coil domains 3 |
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- G alpha (s) signalling events
- Glucagon-type ligand receptors
- ADORA2B mediated anti-inflammatory cytokines production
|
|
- Glucagon recombinant
- Exenatide
- Liraglutide
- Albiglutide
- Dulaglutide
- Lixisenatide
- Semaglutide
|
|
|
|
GNAI1 and NUMA1 |
G protein subunit alpha i1 |
nuclear mitotic apparatus protein 1 |
- PLC beta mediated events
- PLC beta mediated events
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- G-protein activation
- ADP signalling through P2Y purinoceptor 12
- Adrenaline,noradrenaline inhibits insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Regulation of insulin secretion
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
- Extra-nuclear estrogen signaling
- ADORA2B mediated anti-inflammatory cytokines production
|
- Recruitment of NuMA to mitotic centrosomes
- Mitotic Prophase
|
- Guanosine-5'-Diphosphate
- Tetrafluoroaluminate Ion
|
|
|
|
GNAQ and RIC8B |
G protein subunit alpha q |
RIC8 guanine nucleotide exchange factor B |
- Acetylcholine regulates insulin secretion
- Acetylcholine regulates insulin secretion
- G alpha (q) signalling events
- G alpha (q) signalling events
- ADP signalling through P2Y purinoceptor 1
- ADP signalling through P2Y purinoceptor 1
- Thromboxane signalling through TP receptor
- Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
- Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
- Thrombin signalling through proteinase activated receptors (PARs)
|
|
|
|
|
|
GNAS and RIC8B |
GNAS complex locus |
RIC8 guanine nucleotide exchange factor B |
- Glucagon signaling in metabolic regulation
- PKA activation in glucagon signalling
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Prostacyclin signalling through prostacyclin receptor
- Prostacyclin signalling through prostacyclin receptor
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Glucagon-type ligand receptors
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- Glucagon signaling in metabolic regulation
- PKA activation in glucagon signalling
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Prostacyclin signalling through prostacyclin receptor
- Prostacyclin signalling through prostacyclin receptor
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Glucagon-type ligand receptors
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
|
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
|
- Fibrous dysplasia, polyostotic; Albright hereditary osteodystrophy
- Pseudohypoparathyroidism
- Progressive osseous heteroplasia (POH)
|
|
GNAS and SNX13 |
GNAS complex locus |
sorting nexin 13 |
- Glucagon signaling in metabolic regulation
- PKA activation in glucagon signalling
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Prostacyclin signalling through prostacyclin receptor
- Prostacyclin signalling through prostacyclin receptor
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Glucagon-type ligand receptors
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- Glucagon signaling in metabolic regulation
- PKA activation in glucagon signalling
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Prostacyclin signalling through prostacyclin receptor
- Prostacyclin signalling through prostacyclin receptor
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Glucagon-type ligand receptors
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
|
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
|
- Fibrous dysplasia, polyostotic; Albright hereditary osteodystrophy
- Pseudohypoparathyroidism
- Progressive osseous heteroplasia (POH)
|
|
GPR25 and NAALADL2 |
G protein-coupled receptor 25 |
N-acetylated alpha-linked acidic dipeptidase like 2 |
- G alpha (s) signalling events
- ADORA2B mediated anti-inflammatory cytokines production
|
|
|
|
|
|
GRB2 and PDCD6IP |
growth factor receptor bound protein 2 |
programmed cell death 6 interacting protein |
- Interleukin-15 signaling
- Interleukin-15 signaling
|
- Budding and maturation of HIV virion
- Uptake and function of anthrax toxins
|
- Pegademase bovine
- 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
|
|
|
|
GRB2 and ADAM12 |
growth factor receptor bound protein 2 |
ADAM metallopeptidase domain 12 |
- Interleukin-15 signaling
- Interleukin-15 signaling
|
- Signaling by EGFR
- Invadopodia formation
|
- Pegademase bovine
- 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
|
|
|
|
GRM2 and NAALADL2 |
glutamate metabotropic receptor 2 |
N-acetylated alpha-linked acidic dipeptidase like 2 |
- G alpha (i) signalling events
- Class C/3 (Metabotropic glutamate/pheromone receptors)
|
|
|
|
|
|
CXCL1 and MMP9 |
C-X-C motif chemokine ligand 1 |
matrix metallopeptidase 9 |
- Chemokine receptors bind chemokines
- G alpha (i) signalling events
- Interleukin-10 signaling
- Neutrophil degranulation
|
- Signaling by SCF-KIT
- Collagen degradation
- Collagen degradation
- Degradation of the extracellular matrix
- Degradation of the extracellular matrix
- Activation of Matrix Metalloproteinases
- Assembly of collagen fibrils and other multimeric structures
- EPH-ephrin mediated repulsion of cells
- Interleukin-4 and Interleukin-13 signaling
- Neutrophil degranulation
- Extra-nuclear estrogen signaling
|
|
- Glutathione
- Marimastat
- Minocycline
- Captopril
- Glucosamine
- Zinc
- 2-Amino-N,3,3-Trimethylbutanamide
- 2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid
- AE-941
- PG-530742
- 5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE
- (2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE
- (3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID
|
|
- Penile cancer
- Metaphyseal dysplasias, including: Metaphyseal dysplasia, Schmid type; Metaphyseal dysplasia, McKusik type; Metaphyseal dysplasia, Jansen type; Shwachman-Bodian-Diamond syndrome (SBDS); Metaphyseal anadysplasia (MAD)
|
GSK3B and MITF |
glycogen synthase kinase 3 beta |
melanocyte inducing transcription factor |
- Degradation of beta-catenin by the destruction complex
- Beta-catenin phosphorylation cascade
- AKT phosphorylates targets in the cytosol
- Regulation of HSF1-mediated heat shock response
- CRMPs in Sema3A signaling
- Disassembly of the destruction complex and recruitment of AXIN to the membrane
- Disassembly of the destruction complex and recruitment of AXIN to the membrane
- B-WICH complex positively regulates rRNA expression
- Misspliced GSK3beta mutants stabilize beta-catenin
- S33 mutants of beta-catenin aren't phosphorylated
- S37 mutants of beta-catenin aren't phosphorylated
- S45 mutants of beta-catenin aren't phosphorylated
- T41 mutants of beta-catenin aren't phosphorylated
- APC truncation mutants have impaired AXIN binding
- AXIN missense mutants destabilize the destruction complex
- Truncations of AMER1 destabilize the destruction complex
- Degradation of GLI2 by the proteasome
- GLI3 is processed to GLI3R by the proteasome
- Constitutive Signaling by AKT1 E17K in Cancer
- Ubiquitin-dependent degradation of Cyclin D
- Regulation of RUNX2 expression and activity
|
- SUMOylation of transcription factors
|
- Lithium
- 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione
- SB-409513
- N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea
- Staurosporine
- Indirubin-3'-Monoxime
- (3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime
- Alsterpaullone
- Phosphoaminophosphonic Acid-Adenylate Ester
- 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole
- 5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione
- (7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
- N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine
- 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one
- N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide
- 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE
- ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE
- (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
|
|
|
- Ocular albinism; Ocular albinism, type I (OA1); Waardenburg syndrome, type II (WS2-OA)
- Waardenburg syndrome (WS)
- Malignant melanoma
|
GTF2B and DRAP1 |
general transcription factor IIB |
DR1 associated protein 1 |
- HIV Transcription Initiation
- RNA Polymerase II HIV Promoter Escape
- Transcription of the HIV genome
- RNA Polymerase II Pre-transcription Events
- RNA polymerase II transcribes snRNA genes
- RNA polymerase II transcribes snRNA genes
- RNA Polymerase II Promoter Escape
- RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
- RNA Polymerase II Transcription Initiation
- RNA Polymerase II Transcription Initiation And Promoter Clearance
|
- Signaling by NODAL
- Signaling by Activin
|
|
|
|
|